Our portfolio

Haermonics

Innovating post-surgery care, Haermonics develops a device to flush and clean the pericardial space, preventing blood-related complications after open-heart surgery. Their technology reduces the risk of blood clots and subsequent operations. The company is dedicated to improving surgical outcomes through advanced medical devices.

Industry: Cardiology, Medical Technology, Surgery

Want to get in contact about Haermonics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Developing RNA-based therapies for rare genetic heart diseases.
Investing in and developing molecular diagnostics for biotech innovation.
Developing a painless and more accurate mammography technology for breast cancer detection.
Developing portable neurophysiological research tools for EEG and behavioral studies.
Developing RNA-based therapies for rare genetic heart diseases.
Investing in and developing molecular diagnostics for biotech innovation.
Developing a painless and more accurate mammography technology for breast cancer detection.
Developing portable neurophysiological research tools for EEG and behavioral studies.